Assessment of an end-point microassay for yellow fever vaccine.
A statistical analysis was performed on the results obtained in titrations of yellow fever vaccine using a cytopathic end-point microassay in the Vero cell line. The present test system appeared less sensitive than the conventional plaque assay in PS cells but the consistency in titres was satisfactory since both test-to-test and within-test variations were small. In addition, the test is easy to perform, economical and fast.
Husson van Vliet
J
J
Institut d'Hygiène et d-Epidémiologie, Departement Microbiologie, Brussels, Belgium.
D000704:Analysis of Variance; D000818:Animals; D000956:Antigens, Viral; D014709:Vero Cells; D014765:Viral Vaccines / Q000592:standards* / Q000633:toxicity; D015005:Yellow fever virus / Q000276:immunology*
D000956:Antigens, Viral; D014765:Viral Vaccines